Patents Assigned to Califia Bio, Inc.
  • Mixed lineage kinase inhibitors and method of treatments
    Patent number: 9370515
    Abstract: Provided herein are imidazopyridine compounds having an inhibitory effect on mixed lineage kinases (MLKs), methods of their synthesis, and methods of their therapeutic. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and pharmaceutical compositions.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: June 21, 2016
    Assignees: CALIFIA BIO, INC., UNIVERSITY OF ROCHESTER
    Inventors: Val S. Goodfellow, Thong X. Nguyen, Satheesh B. Ravula, Harris A. Gelbard
  • MIXED LINEAGE KINASE INHIBITORS AND METHOD OF TREATMENTS
    Publication number: 20140256733
    Abstract: Provided herein are imidazopyridine compounds having an inhibitory effect on mixed lineage kinases (MLKs), methods of their synthesis, and methods of their therapeutic. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and pharmaceutical compositions.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 11, 2014
    Applicant: Califia Bio, Inc.
    Inventors: VAL S. GOODFELLOW, THONG X. NGUYEN, SATHEESH B. RAVULA, HARRIS A. GELBARD